MeiraGTx Holdings (MGTX) Current Assets (2017 - 2025)
MeiraGTx Holdings (MGTX) posted Current Assets of $91.8 million for Q4 2025, up 168.51% on a QoQ basis from $34.2 million in Q3 2025, and down 25.71% year-over-year from $123.5 million in Q4 2024.
MeiraGTx Holdings (MGTX) Current Assets (2017 - 2025) Analysis & Trends
MeiraGTx Holdings' Current Assets history runs 9 years deep, the most recent figure standing at $91.8 million for Q4 2025.
- Quarterly Current Assets fell 25.71% year-over-year to $91.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $91.8 million (down 25.71% YoY) and the FY2025 annual result came in at $91.8 million, down 25.71% from the prior year.
- Current Assets was $91.8 million for Q4 2025 at MeiraGTx Holdings, up from $34.2 million in the prior quarter.
- Across five years, Current Assets topped out at $230.1 million in Q1 2021 and bottomed at $34.2 million in Q3 2025.
- A 5-year average of $132.9 million and a median of $141.0 million in 2022 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2023 — Current Assets jumped 37.1% — and 2025, when it slumped 75.42%.
- MeiraGTx Holdings' Current Assets stood at $183.2 million in 2021, then decreased by 15.77% to $154.3 million in 2022, then gained by 3.42% to $159.6 million in 2023, then slipped by 22.62% to $123.5 million in 2024, then dropped by 25.71% to $91.8 million in 2025.
- Business Quant data shows MGTX's Current Assets at $91.8 million in Q4 2025, $34.2 million in Q3 2025, and $47.1 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 289.93 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 73.04 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 6.60 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 35.73 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 11.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 18.21 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 521.86 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 8.07 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.97 Bn |
| 10 | MeiraGTx Holdings | 973.21 Mn | 907.27 Mn | - | 91.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 91.76 Mn |
| Sep 30, 2025 | 34.17 Mn |
| Jun 30, 2025 | 47.08 Mn |
| Mar 31, 2025 | 79.89 Mn |
| Dec 31, 2024 | 123.52 Mn |
| Sep 30, 2024 | 139.05 Mn |
| Jun 30, 2024 | 110.77 Mn |
| Mar 31, 2024 | 149.30 Mn |
| Dec 31, 2023 | 159.62 Mn |
| Sep 30, 2023 | 103.53 Mn |
| Jun 30, 2023 | 143.14 Mn |
| Mar 31, 2023 | 121.48 Mn |
| Dec 31, 2022 | 154.34 Mn |
| Sep 30, 2022 | 155.04 Mn |
| Jun 30, 2022 | 104.41 Mn |
| Mar 31, 2022 | 142.93 Mn |
| Dec 31, 2021 | 183.24 Mn |
| Sep 30, 2021 | 176.93 Mn |
| Jun 30, 2021 | 207.04 Mn |
| Mar 31, 2021 | 230.13 Mn |